The Role of Microbiomes in the Development of HPV-cervical Cancer

Posted On 2020-07-09 08:32:52


This series on “The Role of Microbiomes in the Development of HPV-cervical Cancer” is edited by Filipa Godoy-Vitorino, Department of Microbiology & Medical Zoology, UPR School of Medicine, San Juan, Puerto Rico.

Cervical cancer (CC) is the fourth most common female cancer worldwide. Despite the popularized international vaccination efforts against human papillomavirus (HPV)—the primary causative agent of CC—it remains a significant global problem. Indeed, it is the 4th and the 2nd most common cancer in women globally and developing countries.

Editorial
Understanding the role of microbiomes in the development of HPV-cervical cancer
Filipa Godoy-Vitorino

Original Article
The vaginal microbiota, high-risk human papillomavirus infection, and cervical cytology: results from a population-based study
Kimberly S. McKee, Kayla A. Carter, Christine Bassis, Vincent B. Young, Barbara Reed, Diane M. Harper, Mack T. Ruffin IV, Jason D. Bell

Disclosure: 
The series “The Role of Microbiomes in the Development of HPV-cervical Cancer” was commissioned by the editorial office, Gynecology and Pelvic Medicine without any sponsorship or funding. Filipa Godoy-Vitorino served as the unpaid Guest Editor for the series.